REVIA - TAB 50MG
REVIA - TAB 50MG
Discontinued
DIN Number
02158655
Drug Class
Human
Market Date
Dec 31, 1995
Company
HC
dupont merck pharma inc.
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02158655
AIG Number0118591001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
N07BB04 NALTREXONE
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification28:10.00
Health Canada Classification
ACTIVE INGREDIENTS (1)
NALTREXONE HYDROCHLORIDEActive
Strength: 50 MG / TAB
Monograph: NALTREXONE HYDROCHLORIDE